{"schema_version":1,"experiment_id":"eoa_inverse_innovation_exp03_full320_20260801","cell_id":"negative_space_design__pharmacology_toxicology","trajectory_id":"R","attempt_index":0,"archetype_slug":"negative_space_design","domain_slug":"pharmacology_toxicology","decision":"CANDIDATE","problem_id":"sequential_exposure_carryover_in_reusable_toxicology_models","causal_lever_id":"measurement_gated_exposure_free_recovery","proposal":{"problem":"Sequential-compound experiments in reusable organoid or microphysiological toxicology models may begin a new exposure before residual compound, metabolites, or induced biological responses have sufficiently receded, confounding attribution of toxicity to the new compound.","actors_substrate":["toxicology investigators and assay operators","reusable organoid or microphysiological test systems","sequentially administered compounds and metabolites","assay biomarkers, analytical measurements, and protocol records","downstream safety assessors"],"observable_state":"Responses to a compound vary with exposure order; residual analyte or pre-exposure biomarker deviation remains when the next compound is introduced; nominally identical vehicle periods produce different starting states.","consequence":"Carryover and incomplete recovery can be mistaken for compound-specific toxicity, tolerance, or potentiation, producing biased hazard estimates or inconclusive experiments.","affected_objective":"Obtain attributable, reproducible toxicity responses while preserving model viability and reasonable experimental throughput.","structural_mapping":[{"archetype_element":"Crowded field","domain_realization":"Successive exposures occupy the same biological system before chemical and physiological effects from the preceding exposure have cleared.","claim_kind":"INFERENCE"},{"archetype_element":"Deliberate absence","domain_realization":"A protocol-defined interval supplies vehicle or maintenance medium but no test compound.","claim_kind":"HYPOTHESIS"},{"archetype_element":"Protected empty region","domain_realization":"No optional challenge, sensitizer, or new test compound may enter the recovery interval.","claim_kind":"HYPOTHESIS"},{"archetype_element":"Positive form clarified by absence","domain_realization":"The next compound's response becomes more attributable when its starting state is separated from the preceding exposure.","claim_kind":"HYPOTHESIS"},{"archetype_element":"Meaningful boundary and exit","domain_realization":"The interval begins after washout and ends only at prespecified residual-analyte and biomarker-recovery criteria or a maximum duration.","claim_kind":"HYPOTHESIS"},{"archetype_element":"Preserved context","domain_realization":"Vehicle, essential trophic support, environmental control, welfare monitoring, and scheduled measurements continue during compound absence.","claim_kind":"INFERENCE"}],"component_map":[{"component":"Omission Candidate","status":"adapted","domain_realization":"Optional challenges or premature next-compound doses considered for removal from the recovery phase."},{"component":"Protected Empty Space","status":"adapted","domain_realization":"A reserved test-compound-free interval between exposures."},{"component":"Positive Form Relationship","status":"adapted","domain_realization":"The interval isolates the subsequent compound-response relationship."},{"component":"Attention Competition Map","status":"adapted","domain_realization":"A map of residual parent compound, metabolites, adaptive responses, and new-exposure effects competing to explain observations."},{"component":"Absence Boundary","status":"direct","domain_realization":"Protocol timestamps, permitted maintenance inputs, prohibited exposures, and maximum duration define the interval."},{"component":"Clarity or Effect Test","status":"adapted","domain_realization":"Compare residual analyte, baseline recovery, order effects, and response attribution against the baseline protocol."},{"component":"Rest and Pacing Zone","status":"adapted","domain_realization":"The biological recovery phase between active exposures."},{"component":"Meaning-of-Absence Check","status":"direct","domain_realization":"Records distinguish intentional no-exposure from missed dosing, delivery failure, sample loss, or unavailable data."},{"component":"Reintroduction Trigger","status":"adapted","domain_realization":"Resume exposure only after prespecified recovery gates; otherwise terminate at the maximum interval."},{"component":"Accessibility and Recoverability Guardrail","status":"adapted","domain_realization":"Machine-readable phase labels, visible operator alerts, retained schedules, and continued safety monitoring permit audit and controlled resumption."},{"component":"Context Preservation Frame","status":"adapted","domain_realization":"Vehicle controls, required medium, environmental conditions, sampling, and viability checks remain in place."}],"mechanism_dispositions":[{"slug":"architectural_void","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"Its protected-volume analogy is useful but adds no distinct procedure beyond the defined recovery interval.","counterfactual_removal":"Removing it does not change the intervention."},{"slug":"blank_or_rest_frame","disposition":"selected_load_bearing","contribution_type":"CORE_CAUSAL","adaptation_or_rejection":"Adapted into an intentional compound-free phase placed at an exposure boundary and defined by an explicit exit gate.","counterfactual_removal":"Without the protected between-exposure phase, residual and new effects remain temporally superimposed."},{"slug":"editorial_cut","disposition":"selected_supporting","contribution_type":"OPERATIONAL","adaptation_or_rejection":"Screens optional interventions for omission while preserving maintenance inputs, measurements, and a recoverable protocol record.","counterfactual_removal":"The interval could remain, but ad hoc additions could consume it or essential context could be removed indiscriminately."},{"slug":"empty_state_design","disposition":"selected_supporting","contribution_type":"SAFETY_GUARDRAIL","adaptation_or_rejection":"Labels and diagnoses the no-exposure state so intentional recovery is not confused with missed dosing or equipment failure.","counterfactual_removal":"Operators could silently accept genuine protocol failures as deliberate blanks."},{"slug":"facilitation_silence","disposition":"incompatible","contribution_type":"NONE","adaptation_or_rejection":"A group-participation procedure does not address chemical or biological carryover.","counterfactual_removal":"No experimental consequence."},{"slug":"focus_mode_or_control_hiding","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"Hiding controls or monitoring would undermine assay safety and auditability.","counterfactual_removal":"Monitoring remains visible, improving safety."},{"slug":"margin_and_gutter_system","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"Fixed temporal spacing is the nearest rival, but a reusable spacing grammar cannot respond to compound-specific recovery.","counterfactual_removal":"Measurement-gated timing remains intact."},{"slug":"negative_space_logo","disposition":"incompatible","contribution_type":"NONE","adaptation_or_rejection":"Figure-ground symbolism has no causal role in exposure recovery.","counterfactual_removal":"No experimental consequence."},{"slug":"pause_in_speech","disposition":"incompatible","contribution_type":"NONE","adaptation_or_rejection":"Live rhetorical pacing does not alter biological starting state.","counterfactual_removal":"No experimental consequence."},{"slug":"sparse_layout","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"Reducing displayed elements might aid review but would not remove residual compound or adaptation.","counterfactual_removal":"The biological causal chain is unchanged."},{"slug":"whitespace","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"Plot spacing may clarify presentation but does not prevent carryover.","counterfactual_removal":"Only presentation, not exposure attribution, could change."}],"causal_chain":["Withhold the next test compound during a bounded recovery interval.","Continue essential support and measure residual analyte, viability, and selected baseline biomarkers.","Release the next exposure only when prespecified recovery gates are met.","Reduced residual chemical and biological state decreases overlap between consecutive exposure effects.","Lower overlap improves attribution of observed toxicity to the current compound."],"baseline":"Ordinary practice is a fixed-duration wash or medium change followed by the next scheduled compound, often with vehicle controls and randomized exposure order but without state-dependent release criteria.","nearest_rival":"A longer compound-specific fixed washout derived from expected kinetics; it is simpler and faster to schedule but may miss unanticipated metabolites or persistent adaptive responses.","authority_safety":{"affected_parties":["laboratory personnel","donors represented by derived biological materials","downstream safety assessors","patients or populations indirectly affected by hazard decisions"],"decision_authority":"The study principal investigator and assay owner, subject to institutional biosafety, ethics, and quality-system requirements.","authorized_first_step":"Run a preregistered pilot using two compounds in independent reusable model units: compare the existing fixed washout with a recovery-gated interval, cap the interval at one additional planned culture cycle, and measure residual analyte, viability, baseline biomarkers, order effects, and throughput.","excluded_actions":["human or animal dosing","removal of essential medium or trophic support","concealment of failed or missed doses as intentional absence","extension beyond validated culture duration","using recovery gates to declare clinical safety"],"halt_rollback":"Halt a unit if viability or function crosses its existing stop threshold, contamination or delivery failure occurs, or the maximum recovery duration is reached without satisfying gates; retain all records and revert future runs to the validated baseline protocol pending review."}},"negative_tests":{"strongest_counterevidence":"Many toxicology assays use independent single-exposure wells or validated fixed washouts; in those settings sequential carryover is absent or already controlled, so protected absence adds delay without attribution benefit.","analogy_break":"A compound-free interval is not biologically empty: metabolism, tissue remodeling, delayed toxicity, and adaptation continue, and measured baseline recovery cannot prove restoration of the original state.","failure_condition":"The approach fails if recovery markers poorly represent latent carryover, the model changes materially during the interval, or the added delay makes the reusable design less informative than independent units.","problem_falsifier":"Across exposure orders, residual-analyte measurements and pre-exposure biomarkers are already within validated bounds, and subsequent responses show no material order or carryover effect under the baseline protocol.","intervention_falsifier":"Compared with fixed washout, measurement-gated recovery does not reduce residual state, order effects, or response variance, or it improves those outcomes only by unacceptable viability loss or throughput reduction.","risks":["Extended recovery may age or destabilize the model and create a new confounder.","Incomplete marker panels may provide false reassurance while unmeasured adaptation persists.","Variable gates may selectively exclude slow-recovering conditions and bias results.","Operators may mistake delivery failure for intentional no-exposure despite labeling.","Additional washing or maintenance changes may themselves alter toxicity responses."]},"null_rationale":null,"classification":{"candidate_kind":"MECHANISM_ADAPTATION","prior_art_status":"UNSEARCHED","evidence_maturity":"HYPOTHESIS"},"revision_change_log":{"revision_kind":"ORIGINAL","prior_problem_id":null,"prior_causal_lever_id":null,"problem_changed":false,"causal_lever_changed":false,"conceptual_changes":[],"operational_changes":[],"repairs_addressed":[]},"confidence":0.84,"generator_notes":"Closed-book structural transfer. The proposal is limited to reusable sequential-exposure models; it does not apply to independent single-use assay units."}